ONCOLYTICS BIOTECH INC (ONCY:NASDAQ)
$1.12 0.01 (0.9009%)
Analysed ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) News Sources
ONCY: Initiating Coverage of Oncolytics Biotech; A Focused Path to Unlocking the Potential of Pelareorep
07-04-2026
yahoo.com
Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer
06-04-2026
yahoo.com
Oncolytics Biotech’s Nevada Move Resets Capital Access And Dilution Trade Off
01-04-2026
yahoo.com
Oncolytics Biotech® Completes Domicile Change to the United States
01-04-2026
yahoo.com
Oncolytics Biotech® to Present New Mechanistic and Translational Data Supporting Pelareorep as an Immune-Priming Backbone at AACR 2026
19-03-2026
yahoo.com
Oncolytics Biotech® Launches Randomized Colorectal Cancer Study
02-03-2026
yahoo.com
Oncolytics Biotech® to Prioritize Registration-Focused Programs in Anal and Colorectal Cancer
24-02-2026
yahoo.com
Assessing Oncolytics Biotech (ONCY) Valuation After FDA Fast Track Designation For Pelareorep
16-02-2026
yahoo.com
Why Oncolytics Biotech (ONCY) Is Up 19.7% After FDA Fast Track For KRAS-Mutant Colorectal Cancer
15-02-2026
yahoo.com
Oncolytics receives FDA Fast Track Designation for pelareorep
05-02-2026
yahoo.com
What is the current price of ONCOLYTICS BIOTECH INC (ONCY:NASDAQ)?
The current price of ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) is $1.12.
ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) absolute price change since previous trading day?
The absolute price change of ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) since the previous trading day is $0.01.
ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) percentage price change since previous trading day?
The percentage price change of ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) since the previous trading day is 0.9009%.
What is the most recent average sentiment score for ONCOLYTICS BIOTECH INC (ONCY:NASDAQ)?
The most recent average sentiment score for ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for ONCOLYTICS BIOTECH INC (ONCY:NASDAQ)?
The most recent sentiment for ONCOLYTICS BIOTECH INC (ONCY:NASDAQ) is .
SEC-8K** Filing Available For ONCOLYTICS BIOTECH INC (ONCY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.